APA način citiranja

Cruickshank, G., Ngoga, D., Detta, A., Lewis, A., Holden, R., & Fayaye, O. (2018). Local Delivery Of Irinotecan To Recurrent Glioblastoma At Reoperation Offers A Safe Therapeutic Advantage Over Systemic Delivery. Neuro Oncol.

Čikaški stil citiranja

Cruickshank, Garth, Desire Ngoga, Allah Detta, Andy Lewis, Rebecca Holden, i Olufawe Fayaye. "Local Delivery Of Irinotecan To Recurrent Glioblastoma At Reoperation Offers A Safe Therapeutic Advantage Over Systemic Delivery." Neuro Oncol 2018.

MLA način citiranja

Cruickshank, Garth, et al. "Local Delivery Of Irinotecan To Recurrent Glioblastoma At Reoperation Offers A Safe Therapeutic Advantage Over Systemic Delivery." Neuro Oncol 2018.